Get started
Author

Giuseppe Merlino

Observed names: MERLINO, GIUSEPPE, Merlino, Giuseppe
OpenAlex ID: A5106085666
Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
2015 · Marta Giussani, Giuseppe Merlino, et al. · Seminars in Cancer Biology · 158
PDF
Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types
2015 · Paolo Gandellini, Francesca Andriani, et al. · Seminars in Cancer Biology · 140
Extracellular matrix proteins as diagnostic markers of breast carcinoma
2018 · Marta Giussani, Elena Landoni, et al. · Journal of Cellular Physiology · 77
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models
2020 · Eugenio Gaudio, Chiara Tarantelli, et al. · Haematologica · 31
PDF
Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis
2015 · Ilaria Caron, Edoardo Micotti, et al. · PLoS ONE · 27
PDF
MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors
2019 · Giuseppe Merlino, Alessio Fiascarelli, et al. · Molecular Cancer Therapeutics · 24
PDF
Model‐based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2 ‐positive advanced or metastatic breast cancer patients
2023 · Elena M. Tosca, Elisa Borella, et al. · CPT Pharmacometrics & Systems Pharmacology · 14
PDF
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
2023 · Alessio Fiascarelli, Giuseppe Merlino, et al. · Breast Cancer Research and Treatment · 10
PDF
Prognostic and functional role of subtype‐specific tumor–stroma interaction in breast cancer
2017 · Giuseppe Merlino, Patrizia Miodini, et al. · Molecular Oncology · 10
PDF
In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays
2015 · Maurizio Callari, Alessandro Guffanti, et al. · Oncotarget · 9
PDF
Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer
2016 · Giuseppe Merlino, Patrizia Miodini, et al. · Microarrays · 8
PDF
Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/−/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611
2021 · Manuela Ceccarelli, Giorgio D’Andrea, et al. · Frontiers in Oncology · 7
PDF
The Dual PIM / FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3 ‐ ITD ‐Mutant Acute Myeloid Leukaemia
2024 · Sonia Zicari, Giuseppe Merlino, et al. · Journal of Cellular and Molecular Medicine · 5
PDF
Abstract 2160: MEN1611, a novel α-selective PI3K inhibitor in solid tumors
2018 · Giuseppe Merlino, Alessio Fiascarelli, et al. · Cancer Research · 5
CD205-Shuttle study: A first-in-human trial of MEN1309/OBT076 an ADC targeting CD205 in solid tumor and NHL.
2018 · Elena Garralda, Josep Tabernero, et al. · Journal of Clinical Oncology · 3
The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway
2023 · Giuliana Papoff, Dario Presutti, et al. · Frontiers in Oncology · 2
Abstract 2849: The oral SERD Elacestrant in combination with the PI3K inhibitor MEN1611 inhibits tumor growth in ER+/HER2- breast cancer in vitro and in PDX models
2023 · Giuseppe Merlino, Alessio Fiascarelli, et al. · Cancer Research · 2
Abstract 2630: MEN1309, a novel antibody drug conjugate (ADC) targeting Ly75 antigen, induces complete responses in several xenografts of solid tumors
2017 · Mario Bigioni, Giuseppe Merlino, et al. · Cancer Research · 1
CD205, a target antigen for a novel antibody drug conjugate (ADC): Evaluation of antigen expression on non-Hodgkin lymphoma (NHL).
2017 · Vincenzo Canzonieri, Valter Gattei, et al. · Journal of Clinical Oncology · 1
MaNgROVIVIRga CUNICULI gen. nov., sp. nov., a moderately halophilic bacterium isolated from bioturbated Red Sea mangrove sediment, and proposal of the novel family MaNgROVIVIRgaCeae fam. nov.
2026 · Sefrji, Fatmah O., Michoud, Grégoire, et al. · The Catalogue of Life
Abstract 665: MEN1703/SEL24 exhibits promising antitumoral activity in preclinical models of myelofibrosis both as single agent and combined with ruxolitinib
2024 · Maria Luisa Iannitto, Diego Bisignano, et al. · Cancer Research
Data from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors
2023 · Giuseppe Merlino, Alessio Fiascarelli, et al.
Supplementary Data from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors
2023 · Giuseppe Merlino, Alessio Fiascarelli, et al.
Supplementary Figure S1 from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors
2023 · Giuseppe Merlino, Alessio Fiascarelli, et al.
Supplementary Figure S2 from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors
2023 · Giuseppe Merlino, Alessio Fiascarelli, et al.
Works count: 62
Citation count: 534
H-index: 9
I10-index: 9
Year
Topic
Type